If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 271 - 280 of 281
Concept Representation in the Human Brain
Objective
Concept Representation in the Human Brain
Protocol No
NEURO-NIH-CONCEPT-REP-BRAIN
The Intersection of GLP-1, Gut Microbiota, and Brain Connectivity in Prodromal Alzheimer's Disease
Objective
GLP-1, Gut Microbiota, and Brain Connectivity in AD
Protocol No
NEURO-NIH-MICROBIOME-GLP-1-AD
Preventing Common Obstetric Complications Through an Immersive, Medically Tailored Meal Program (PLATE)
Objective
Preventing Common Obstetric Complications Through an Immersive, Medically Tailored Meal Program
Protocol No
OBG-IIT-PALATNIK-AHW-PLATE
Categories
Gestational Diabetes and Pharmacotherapy (GAP) - A Randomized Controlled Trial Investigating Timing of Pharmacotherapy Initiation for Patients With Gestational Diabetes
Objective
Gestational Diabetes and Pharmacotherapy (GAP)
Protocol No
OBG-IIT-PALATNIK-GAP
Categories
A Multicenter Study to Assess the Safety and Effectiveness of the Genio Dual-sided Hypoglossal Nerve Stimulation System for the Treatment of Obstructive Sleep Apnea in Adults Subjects
Objective
Dual-sided Hypoglossal neRvE stimulAtion for the treatMent of Obstructive Sleep Apnea (DREAM)
Protocol No
OTO-NYXOAH-DREAM-STUDY
Categories
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Objective
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)
Protocol No
NRG-GI008-CIRCULATE-NA
Categories
Asciminib as Initial Therapy with Addition of Lower Dose Tyrosine Kinase Inhibitors for Patients with Chronic Myeloid Leukemia Who Do Not Achieve a Deep Molecular Remission
Objective
Asciminib As Initial Therapy For Patients With Chronic Myeloid Leukemia In Chronic Phase
Protocol No
HJKC3-0004
Categories
A Phase 2a/2b, Open-label, Proof of Concept (Phase 2a) and Open-label (Phase 2b), Multicenter, Efficacy, and Safety Study of AG-946 in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes
Objective
A study of AG-946 in patients with anemia due to LR-MDS
Protocol No
AGIOS-AG946-C-002
Categories
Randomized Phase II/III Trial of Consolidation Radiation + Immunotherapy for ES-SCLC: RAPTOR Trial
Objective
Testing the addition of radiation therapy to the usual immune therapy treatment (atezolizumab) for patients with extensive stage small cell lung cancer
Protocol No
NRG-LU007
Categories
A Dose Escalation and Expansion Study of ABBV-383 in Combination with Anti-Cancer Regimens for the Treatment of Patients with Relapsed/Refractory Multiple Myeloma
Objective
A Study of Abbvie M22-947 in Patients with Relapsed Refractory Multiple Myeloma
Protocol No
ABBVIE-M22-947
Categories